Ground-breaking Huntington's drug set for global study
Listen to UCL/UCLH researcher Sarah Tabrizi talk about how researchers are set to carry out a large-scale, global study of a ground-breaking Huntington’s disease drug.
Dr Rishi Gupta, NIHR Doctoral Research Fellow and Infectious Disease Epidemiologist at UCL Institute for Global Health, discusses the development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19.
UCLH patients shared their views on how patient data should be used for research at the BRC’s sold-out event Your data, our challenge which was streamed across UCLH and UCL.
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more.